5.72
-1.04%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Beijing Tong Ren Tang Chinese Medicine Co
Its shares trade on HKEX under the ticker 3613.HK. It has been listed since 7 May 2013. In the fiscal year to 31 December 2025, it reported revenue of HK$1.51bn and net income of HK$397.2m. At that date it held total assets of HK$4.66bn and shareholders' equity of HK$4.19bn.
Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products. The company employs 766 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 7 May 2013
- Employees
- 766
- Website
- cm.tongrentang.com ↗
Leadership
Pay as last reported
- Mr. Han YanExecutive Chairman of the Board, since 2025
- Mr. Chi WangChief Executive Officer, Executive Director, since 2024HK$1.2m
- Mr. Zheng YueExecutive Vice Chairman of the Board, since 2025
- Ms. Fung Yi TsangChief Financial Officer, Company Secretary
- Ms. Wei WuDeputy General Manager
- Mr. Jiliang ZhangDeputy General Manager
- Ms. Li FengNon-Executive Director, since 2022
- Mr. Ngai Chi ChanIndependent Non-Executive DirectorHK$288,000
- Mr. Yok Sing TsangIndependent Non-Executive DirectorHK$288,000
- Mr. Hong Xi XuIndependent Non-Executive DirectorHK$288,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Beijing Tong Ren Tang Chinese Medicine Co Ltd has several strengths that contribute to its success in the Chinese medicine industry:
Weaknesses
- Despite its strengths, Beijing Tong Ren Tang also faces certain weaknesses:
Opportunities
- Beijing Tong Ren Tang can capitalize on various opportunities to further enhance its position in the market:
Threats
- Beijing Tong Ren Tang faces certain threats that may pose challenges to its growth and sustainability:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.